Terms: = Germ cell tumor AND ABCG2, ABC15, ABCP, BCRP, BCRP1, BMDP, CD338, CDw338, EST157481, GOUT1, MRX, MXR, MXR-1, MXR1, UAQTL1
207 results:
1. abcg2 Expression as a Potential Survival Predictor in Human Gliomas.
Raguž M; Tarle M; Müller D; Tomasović-Lončarić Č; Chudy H; Marinović T; Chudy D
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542090
[TBL] [Abstract] [Full Text] [Related]
2. Identification of Novel, Selective Ataxia-Telangiectasia Mutated Kinase Inhibitors with the Ability to Penetrate the Blood-Brain Barrier: The Discovery of AZD1390.
Pike KG; Hunt TA; Barlaam B; Benstead D; Cadogan E; Chen K; Cook CR; Colclough N; Deng C; Durant ST; Eatherton A; Goldberg K; Johnström P; Liu L; Liu Z; Nissink JWM; Pang C; Pass M; Robb GR; Roberts C; Schou M; Steward O; Sykes A; Yan Y; Zhai B; Zheng L
J Med Chem; 2024 Feb; 67(4):3090-3111. PubMed ID: 38306388
[TBL] [Abstract] [Full Text] [Related]
3. Evaluation of ABT-751, a novel anti-mitotic agent able to overcome multi-drug resistance, in melanoma cells.
Mahgoub TM; Jordan EJ; Mahdi AF; Oettl V; Huefner S; O'Donovan N; Crown J; Collins DM
Cancer Chemother Pharmacol; 2024 May; 93(5):427-437. PubMed ID: 38226983
[TBL] [Abstract] [Full Text] [Related]
4. Association of abcg2 Polymorphisms on Triple Negative Breast Cancer (TNBC) Susceptibility Risk.
Hao Ing Y; Md Salleh MS; Yahya MM; Ankathil R; Abdul Aziz AA
Asian Pac J Cancer Prev; 2023 Nov; 24(11):3891-3897. PubMed ID: 38019248
[TBL] [Abstract] [Full Text] [Related]
5. Acquired and intrinsic resistance to vemurafenib in BRAF
Zhang P; Kuil LE; Buil LCM; Freriks S; Beijnen JH; van Tellingen O; de Gooijer MC
FEBS Open Bio; 2024 Jan; 14(1):96-111. PubMed ID: 37953496
[TBL] [Abstract] [Full Text] [Related]
6. Putative Cancer Stem cell Markers are Frequently Expressed by Melanoma cells
Speigl L; Janssen N; Weide B; Sinnberg T; Pawelec G; Shipp C
Front Biosci (Landmark Ed); 2023 Sep; 28(9):193. PubMed ID: 37796710
[TBL] [Abstract] [Full Text] [Related]
7. PGC1-α-driven mitochondrial biogenesis contributes to a cancer stem cell phenotype in melanoma.
Fontana F; Macchi C; Anselmi M; Rizzuto AS; Ruscica M; Limonta P
Biochim Biophys Acta Mol Basis Dis; 2024 Jan; 1870(1):166897. PubMed ID: 37758066
[TBL] [Abstract] [Full Text] [Related]
8. Targeting MAGI2-AS3-modulated Akt-dependent ATP-binding cassette transporters as a possible strategy to reverse temozolomide resistance in temozolomide-resistant glioblastoma cells.
Chen Z; Zhou J; Liu Y; Ni H; Zhou B
Drug Dev Res; 2023 Nov; 84(7):1482-1495. PubMed ID: 37551766
[TBL] [Abstract] [Full Text] [Related]
9. Identification of HDAC4 as a potential therapeutic target and prognostic biomarker for ZFTA-fused ependymomas.
de Sousa GR; Salomão KB; Nagano LFP; Riemondy KA; Chagas PS; Veronez LC; Saggioro FP; Marie SKN; Yunes JA; Cardinalli IA; Brandalise SR; de Paula Queiroz RG; Scrideli CA; Donson AM; Foreman NK; Tone LG; Valera ET
Cancer Gene Ther; 2023 Aug; 30(8):1105-1113. PubMed ID: 37041276
[TBL] [Abstract] [Full Text] [Related]
10. Cancer Stem cell and Aggressiveness Traits Are Promoted by Stable Endothelin-Converting Enzyme-1c in Glioblastoma cells.
Niechi I; Erices JI; Carrillo-Beltrán D; Uribe-Ojeda A; Torres Á; Rocha JD; Uribe D; Toro MA; Villalobos-Nova K; Gaete-Ramírez B; Mingo G; Owen GI; Varas-Godoy M; Jara L; Aguayo F; Burzio VA; Quezada-Monrás C; Tapia JC
Cells; 2023 Feb; 12(3):. PubMed ID: 36766848
[TBL] [Abstract] [Full Text] [Related]
11. Neuropilin-2 Inhibits Drug Resistance and Progression of Melanoma Involving the MiR-331-3p Regulated Cascade.
Xie Q; Zhang R; Liu D; Yang J; Hu Q; Shan C; Li X
Curr Mol Pharmacol; 2023; 16(7):787-799. PubMed ID: 36545728
[TBL] [Abstract] [Full Text] [Related]
12. Differences of macrophages in the tumor microenvironment as an underlying key factor in glioma patients.
Wang Y; Liu Y; Zhang C; Zhang C; Guan X; Jia W
Front Immunol; 2022; 13():1028937. PubMed ID: 36389681
[TBL] [Abstract] [Full Text] [Related]
13. Expression of ABCB1, ABCC1 and 3 and abcg2 in glioblastoma and their relevance in relation to clinical survival surrogates.
Roy LO; Lemelin M; Blanchette M; Poirier MB; Aldakhil S; Fortin D
J Neurooncol; 2022 Dec; 160(3):601-609. PubMed ID: 36342588
[TBL] [Abstract] [Full Text] [Related]
14. CRISPR/Cas9-induced knockout reveals the role of ABCB1 in the response to temozolomide, carmustine and lomustine in glioblastoma multiforme.
Radtke L; Majchrzak-Celińska A; Awortwe C; Vater I; Nagel I; Sebens S; Cascorbi I; Kaehler M
Pharmacol Res; 2022 Nov; 185():106510. PubMed ID: 36252775
[TBL] [Abstract] [Full Text] [Related]
15. p38 MAPK-dependent phosphorylation of transcription factor SOX2 promotes an adaptive response to BRAF inhibitors in melanoma cells.
Pietrobono S; De Paolo R; Mangiameli D; Marranci A; Battisti I; Franchin C; Arrigoni G; Melisi D; Poliseno L; Stecca B
J Biol Chem; 2022 Sep; 298(9):102353. PubMed ID: 35944584
[TBL] [Abstract] [Full Text] [Related]
16. Preliminary Study on Relationship Between Temozolomide Chemotherapy-Resistant cells and Stem cells in Gliomas.
Min X; Dingchao X; Xun Z; Cunzu W
Turk Neurosurg; 2022; 32(3):357-363. PubMed ID: 35615767
[TBL] [Abstract] [Full Text] [Related]
17. Inhibition of abcg2 transporter by lapatinib enhances 5-aminolevulinic acid-mediated protoporphyrin IX fluorescence and photodynamic therapy response in human glioma cell lines.
Mansi M; Howley R; Chandratre S; Chen B
Biochem Pharmacol; 2022 Jun; 200():115031. PubMed ID: 35390338
[TBL] [Abstract] [Full Text] [Related]
18. Poloxamer-linked prodrug of a topoisomerase I inhibitor SN22 shows efficacy in models of high-risk neuroblastoma with primary and acquired chemoresistance.
Alferiev IS; Guerrero DT; Guan P; Nguyen F; Kolla V; Soberman D; Pressly BB; Fishbein I; Brodeur GM; Chorny M
FASEB J; 2022 Mar; 36(3):e22213. PubMed ID: 35192728
[TBL] [Abstract] [Full Text] [Related]
19. Ko143 Reverses MDR in Glioblastoma
Lustig SD; Kodali SK; Longo SL; Kundu S; Viapiano MS
Anticancer Res; 2022 Feb; 42(2):723-730. PubMed ID: 35093870
[TBL] [Abstract] [Full Text] [Related]
20. Analysis of Factors Affecting 5-ALA Fluorescence Intensity in Visualizing Glial tumor cells-Literature Review.
Mazurek M; Szczepanek D; Orzyłowska A; Rola R
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055109
[TBL] [Abstract] [Full Text] [Related]
[Next]